Risk factors

Glucosamine cardiovascular ‘benefit’ doesn’t stand up to scrutiny

An observational study purporting to show the widely-used joint pain supplement glucosamine may reduce cardiovascular disease has been met with scepticism by Australian experts. Published in the BMJ, the analysis of data from 466,039 people without cardiovascular disease found a 15% lower risk of cardiovascular events  during seven years of follow up among those who ...

Already a member?

Login to keep reading.

© 2021 the limbic